Clinical trial

A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer

NCT00252811

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2004-02-01

PhasePHASE2

Study timeline

Study start (unknown)2004-02-01Date precision: month

Registry last updated2011-01-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

GefitinibDRUG · verified · RxNorm: gefitinib

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

MilanItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00252811 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.